Phase I Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive Non-Small Cell Lung Cancer (JVDF)

被引：1
|
作者：
Herbst, R. [1 ]
Arkenau, H. [2 ]
Bendell, J. [3 ]
Arrowsmith, E. [4 ]
Wermke, M. [5 ]
Soriano, A. [6 ]
Penel, N. [7 ]
Santana-Davila, R. [8 ]
Bischoff, H. [9 ]
Chau, I. [10 ]
Chao, B. [11 ]
Ferry, D. [11 ]
Mi, G. [12 ]
Paz-Ares, L. [13 ]
机构：
[1] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA
[2] UCL, Sarah Cannon Res Inst, London, England
[3] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[4] Tennessee Oncol, Nashville, TN USA
[5] Univ Hosp Carl Gustav Carus, Dresden, Germany
[6] Florida Canc Specialists, Englewood, FL USA
[7] Ctr Oscar Lambret, Lille, France
[8] Univ Washington, Seattle, WA 98195 USA
[9] Thoraxklin Heidelberg Ggmbh, Heidelberg, Germany
[10] Royal Marsden Hosp, Sutton, Surrey, England
[11] Eli Lilly & Co, New York, NY USA
[12] Eli Lilly & Co, Indianapolis, IN 46285 USA
[13] 12 Octubre Univ Hosp, Seville, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Ramucirumab; Pembrolizumab; Lung cancer;
D O I：
10.1016/j.jtho.2019.08.615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA14.07
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [1] Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC
    Herbst, Roy S.
    Arkenau, Hendrik Tobias
    Bendell, Johanna
    Arrowsmith, Edward
    Wermke, Martin
    Soriano, Andres
    Penel, Nicolas
    Santana-Davila, Rafael
    Bischoff, Helge
    Chau, Ian
    Mi, Gu
    Wang, Hong
    Rasmussen, Erik
    Ferry, David
    Chao, Bo H.
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : 289 - 298
  • [2] Ramucirumab for the treatment of advanced or metastatic non-small cell lung cancer
    Takeda, Koji
    Daga, Haruko
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (12) : 1541 - 1547
  • [3] A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer
    Huang, Chun-Yao
    Huang, Hui-Li
    Lan, Chou-Chin
    Huang, Yi-Chih
    Wu, Yao-Kuang
    BMC CANCER, 2023, 23 (01)
  • [4] Ramucirumab in Combination with Pembrolizumab in Treatment-Naive Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial
    Chau, Ian
    Penel, Nicolas
    Soriano, Andres O.
    Arkenau, Hendrik-Tobias
    Cultrera, Jennifer
    Santana-Davila, Rafael
    Calvo, Emiliano
    Le Tourneau, Christophe
    Zender, Lars
    Bendell, Johanna C.
    Mi, Gu
    Gao, Ling
    McNeely, Samuel Clark
    Oliveira, Joana M.
    Ferry, David
    Herbst, Roy S.
    Fuchs, Charles S.
    CANCERS, 2020, 12 (10) : 1 - 16
  • [5] The role of pembrolizumab in the treatment of advanced non-small cell lung cancer
    Santabarbara, Giuseppe
    Maione, Paolo
    Rossi, Antonio
    Palazzolo, Giovanni
    Gridelli, Cesare
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
  • [6] Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
    Paz-Ares, Luis G.
    Perol, Maurice
    Ciuleanu, Tudor-Eliade
    Kowalyszyn, Ruben Dario
    Reck, Martin
    Lewanski, Conrad R.
    Syrigos, Konstantinos
    Arrieta, Oscar
    Prabhash, Kumar
    Park, Keunchil
    Pikiel, Joanna
    Goksel, Tuncay
    Lee, Pablo
    Zimmermann, Anna
    Carter, Gebra Cuyun
    Alexandris, Ekaterine
    Garon, Edward B.
    LUNG CANCER, 2017, 112 : 126 - 133
  • [7] Pembrolizumab for the treatment of non-small cell lung cancer
    Muller, Mirte
    Schouten, Robert D.
    De Gooijer, Cornedine J.
    Baas, Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 399 - 409
  • [8] Pembrolizumab for the treatment of non-small cell lung cancer
    Lim, Sung Hee
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 397 - 406
  • [9] The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer
    Sakaguchi, Tadashi
    Furuya, Naoki
    Ito, Kentaro
    Hida, Naoya
    Morikawa, Kei
    Komase, Yuko
    Inoue, Takeo
    Hataji, Osamu
    Mineshita, Masamichi
    THORACIC CANCER, 2020, 11 (06) : 1559 - 1565
  • [10] Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer
    Low, Jia Li
    Huang, Yiqing
    Sooi, Kenneth
    Ang, Yvonne
    Chan, Zhi Yao
    Spencer, Katie
    Jeyasekharan, Anand Devaprasath
    Sundar, Raghav
    Goh, Boon Cher
    Soo, Ross
    Yong, Wei Peng
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (01) : 169 - 176
12345